AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Dexmedetomidine Hydrochloride in South Africa

9 products registered with SAHPRA — 9 active

Brand / ProductReg. No.HolderStatusExpires
DEXITHERA 100 µg/ml 10 ml56/2.9/0941Abbott Laboratories S.A. (Pty) Ltdactive26 Nov 2029
DEXITHERA 100 µg/ml 2 ml56/2.9/0939Abbott Laboratories S.A. (Pty) Ltdactive26 Nov 2029
DEXITHERA 100 µg/ml 4 ml56/2.9/0940Abbott Laboratories S.A. (Pty) Ltdactive26 Nov 2029
TOMEXA 1000 µg/10 ml56/2.2/0235Pharmacorp (Pty) Ltdactive11 Jun 2029
TOMEXA 200 µg/2 ml56/2.2/0233Pharmacorp (Pty) Ltdactive11 Jun 2029
TOMEXA 400 µg/4 ml560/2.2/0234Pharmacorp (Pty) Ltdactive11 Jun 2029
SEDMEDEX 100 μg/ml54/2.9/0696Juno Pharma SA (Pty) Ltdactive21 Feb 2028
SESODEX55/2.9/0841Austell Pharmaceuticals (Pty) Ltdactive7 Feb 2028
EUSEDEX56/2.9/0850Pfizer Laboratories (Pty) Ltdactive11 Oct 2027

Dexmedetomidine Hydrochloride — SAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Dexmedetomidine Hydrochloride, of which 9 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Dexmedetomidine Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.